Cancer regression in patients after transfer of genetically engineered lymphocytes.-论文-万方医学网

作者： Richard A,Morgan ^[1] ; Mark E,Dudley ; John R,Wunderlich ; Marybeth S,Hughes ; James C,Yang ; Richard M,Sherry ; Richard E,Royal ; Suzanne L,Topalian ; Udai S,Kammula ; Nicholas P,Restifo ; Zhili,Zheng ; Azam,Nahvi ; Christiaan R,de Vries ; Linda J,Rogers-Freezer ; Sharon A,Mavroukakis ; Steven A,Rosenberg

作者单位： Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA. ^[1]

主题词过继转移(Adoptive Transfer);成年人(Adult);抗原, 肿瘤(Antigens, Neoplasm);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌症疫苗(Cancer Vaccines);细胞, 培养的(Cells, Cultured);电穿孔(Electroporation);女(雌)性(Female);遗传工程(Genetic Engineering);HLA-A抗原(HLA-A Antigens);HLA-A2抗原(HLA-A2 Antigen);人类(Humans);白细胞介素2(Interleukin-2);MART-1抗原(MART-1 Antigen);男(雄)性(Male);黑色素瘤(Melanoma);中年人(Middle Aged);肿瘤蛋白质类(Neoplasm Proteins);受体, 抗原, T细胞, α-β(Receptors, Antigen, T-Cell, alpha-beta);转导, 遗传(Transduction, Genetic);转基因(Transgenes)

DOI 10.1126/science.1129003

PMID 16946036

发布时间 2023-11-20

检索历史清除

Cancer regression in patients after transfer of genetically engineered lymphocytes.

Science (New York, N.Y.)

相似文献

Science (New York, N.Y.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cancer regression in patients after transfer of genetically engineered lymphocytes.

Science (New York, N.Y.)

相似文献

Science (New York, N.Y.)

相关期刊

检索历史清除